
All records · Back to the record · Dossier (sources.md) · Terminology · Report a problem · Comments
Everything a reviewer needs to judge, gathered from the record. Release status: draft.
| Review | Status | Reviewer | Date | Notes |
|---|---|---|---|---|
| schema validation | not_started | Run scripts/build.ps1 -Conformance. | ||
| clinical review | not_started | Awaiting clinician review; check allopurinol titration in stage 3a CKD, colchicine with atorvastatin, potassium citrate with losartan, and the two titration and potassium-check deviations recorded. | ||
| provenance review | not_started | Gutenberg editions of his letters, works, and autobiography, two PubMed abstracts, and an American Battlefield Trust biography logged; Founders Online could not be fetched (bot challenge). Lead poisoning is graded R, possible. | ||
| safe messaging review | not_started | No behavioral-health content; laudanum use in his last year is recorded only as historical fact; death recorded without graphic detail. |
Checks the monitoring protocol called for that the schedule did not perform. Each is recorded with its outcome and corrective action, never filled with an invented result.
| Visit | Measure | Interval | What happened |
|---|---|---|---|
| 2026-05-18 Progress note 03 (C-CDA) | Serum urate 2 to 5 weeks after raising allopurinol to 200 mg | Once after each dose change | Not drawn in the window, a deviation from the protocol; the surgery fell in that period and the check was not rebooked. It is seven weeks today. No harm: no flare, and the dose is raised today. Corrective action: a standing urate order every four weeks until target |
| 2026-09-14 Progress note 05 (C-CDA) | Serum urate 2 to 5 weeks after raising allopurinol to 300 mg | Once after each dose change | Not drawn in the window, a deviation from the protocol; the first value came at the July flare visit at seven weeks (5.9 mg/dL, unreliable during a flare). No change in management resulted, and today's 5.4 confirms the target. Corrective action: the standing order now prints at each visit |
| 2026-09-14 Progress note 05 (C-CDA) | Potassium 2 to 4 weeks after starting potassium citrate with losartan in chronic kidney disease | Once after starting; then periodically | Not drawn in the window, a deviation from the protocol; first checked at the July sick visit at seven weeks (4.7 mmol/L). No harm: potassium 4.6 today. Corrective action: potassium is added to the standing order whenever a potassium-raising drug is started |
| 2026-09-14 Progress note 05 (C-CDA) | Three-month post-procedural urologic check | About 3 months after the procedure | No separate visit was held at three months, a deviation from the follow-up schedule; urinary symptoms were reviewed and negative at the July sick visit. No harm: IPSS and residual are normal today |
None.
| Claim | Statement | Certainty |
|---|---|---|
| CLM-0004 | The same review argues that several factors that raise uric acid converged in him, including sex, genetics, diet, drinking, advanced age, psoriasis, and possible lead poisoning from lead exposure. | possible |
| CLM-0016 | A 2023 review describes him as overweight and as probably having had consequences of the metabolic syndrome, including gout. | possible |
None.
None.
Every note in the record, with its type. All clinical content is synthetic.
| Date | Result | Value | Flag |
|---|---|---|---|
| 2026-03-02 | Serum urate | 9.1 mg/dL (high) | High |
| 2026-03-02 | Creatinine | 1.36 mg/dL (high) | High |
| 2026-03-02 | eGFR | 54 mL/min/1.73 m² (low) | Low |
| 2026-03-02 | LDL cholesterol | 128 mg/dL (high) | High |
| 2026-03-02 | Urine red cells | 12 /[HPF] (high) | High |
| 2026-03-30 | Serum urate | 7.6 mg/dL (high) | High |
| 2026-03-30 | eGFR | 55 mL/min/1.73 m² (low) | Low |
| 2026-03-30 | Post-void residual volume by bladder ultrasound | 160 mL (high) | High |
| 2026-03-30 | Maximum urine flow rate (Qmax) | 8.5 mL/s (low) | Low |
| 2026-05-18 | eGFR | 56 mL/min/1.73 m² (low) | Low |
| 2026-05-18 | 24-hour urine volume | 1.45 L/(24.h) (low) | Low |
| 2026-05-18 | 24-hour urine uric acid | 840 mg/(24.h) (high) | High |
| 2026-09-14 | eGFR | 56 mL/min/1.73 m² (low) | Low |
| 2026-07-06 | eGFR | 55 mL/min/1.73 m² (low) | Low |
| 2026-07-06 | Glucose | 104 mg/dL (high) | High |